BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wright BL, Fernandez-Becker NQ, Kambham N, Purington N, Tupa D, Zhang W, Rank MA, Kita H, Shim KP, Bunning BJ, Doyle AD, Jacobsen EA, Boyd SD, Tsai M, Maecker H, Manohar M, Galli SJ, Nadeau KC, Chinthrajah RS. Baseline Gastrointestinal Eosinophilia Is Common in Oral Immunotherapy Subjects With IgE-Mediated Peanut Allergy. Front Immunol 2018;9:2624. [PMID: 30524424 DOI: 10.3389/fimmu.2018.02624] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Nicolaides RE, Parrish CP, Bird JA. Food Allergy Immunotherapy with Adjuvants. Immunology and Allergy Clinics of North America 2020;40:149-73. [DOI: 10.1016/j.iac.2019.09.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
2 Tang ML, Lozinsky AC, Loke P. Peanut Oral Immunotherapy. Immunology and Allergy Clinics of North America 2020;40:97-110. [DOI: 10.1016/j.iac.2019.09.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
3 Wright BL, Fernandez-Becker NQ, Kambham N, Purington N, Cao S, Tupa D, Zhang W, Sindher SB, Rank MA, Kita H, Katzka DA, Shim KP, Bunning BJ, Doyle AD, Jacobsen EA, Tsai M, Boyd SD, Manohar M, Chinthrajah RS. Gastrointestinal Eosinophil Responses in a Longitudinal, Randomized Trial of Peanut Oral Immunotherapy. Clin Gastroenterol Hepatol 2021;19:1151-1159.e14. [PMID: 32434067 DOI: 10.1016/j.cgh.2020.05.019] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
4 Sampath V, Sindher SB, Alvarez Pinzon AM, Nadeau KC. Can food allergy be cured? What are the future prospects? Allergy 2020;75:1316-26. [PMID: 31733120 DOI: 10.1111/all.14116] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
5 Chen PH, Anderson L, Zhang K, Weiss GA. Eosinophilic Gastritis/Gastroenteritis. Curr Gastroenterol Rep 2021;23:13. [PMID: 34331146 DOI: 10.1007/s11894-021-00809-2] [Reference Citation Analysis]
6 Long A, Borro M, Sampath V, Chinthrajah RS. New Developments in Non-allergen-specific Therapy for the Treatment of Food Allergy. Curr Allergy Asthma Rep 2020;20:3. [PMID: 31950290 DOI: 10.1007/s11882-020-0897-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
7 Chu DK, Spergel JM, Vickery BP. Management of Eosinophilic Esophagitis During Oral Immunotherapy. J Allergy Clin Immunol Pract 2021;9:3282-7. [PMID: 34325036 DOI: 10.1016/j.jaip.2021.07.017] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Anderson B, Wong L, Adlou B, Long A, Chinthrajah RS. Oral Immunotherapy in Children: Clinical Considerations and Practical Management. J Asthma Allergy 2021;14:1497-510. [PMID: 34934327 DOI: 10.2147/JAA.S282696] [Reference Citation Analysis]
9 Dunlop JH. Oral immunotherapy for treatment of peanut allergy. J Investig Med 2020;68:1152-5. [PMID: 32665367 DOI: 10.1136/jim-2020-001422] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Chinthrajah RS, Purington N, Andorf S, Long A, O'Laughlin KL, Lyu SC, Manohar M, Boyd SD, Tibshirani R, Maecker H, Plaut M, Mukai K, Tsai M, Desai M, Galli SJ, Nadeau KC. Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study. Lancet 2019;394:1437-49. [PMID: 31522849 DOI: 10.1016/S0140-6736(19)31793-3] [Cited by in Crossref: 66] [Cited by in F6Publishing: 27] [Article Influence: 22.0] [Reference Citation Analysis]
11 Goldberg MR, Nachshon L, Levy MB, Elizur A, Katz Y. Risk Factors and Treatment Outcomes for Oral Immunotherapy-Induced Gastrointestinal Symptoms and Eosinophilic Responses (OITIGER). J Allergy Clin Immunol Pract 2020;8:125-31. [PMID: 31382040 DOI: 10.1016/j.jaip.2019.07.034] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
12 Hamant L, Freeman C, Garg S, Wright BL, Schroeder S. Eosinophilic esophagitis may persist after discontinuation of oral immunotherapy. Ann Allergy Asthma Immunol 2021;126:299-302. [PMID: 33340664 DOI: 10.1016/j.anai.2020.12.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
13 Votto M, De Filippo M, Caminiti L, Carella F, de Castro G, Landi M, Olcese R, Vernich M, Marseglia GL, Ciprandi G, Barberi S. Eosinophilic gastrointestinal disorders and allergen immunotherapy: Lights and shadows. Pediatr Allergy Immunol 2021;32:814-23. [PMID: 33503273 DOI: 10.1111/pai.13458] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Ruffner MA, Capucilli P, Hill DA, Spergel JM. Screening children for eosinophilic esophagitis: allergic and other risk factors. Expert Rev Clin Immunol 2019;15:315-8. [PMID: 30722709 DOI: 10.1080/1744666X.2019.1579643] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Cianferoni A. Eosinophilic Esophagitis as a Side Effect of Food Oral Immunotherapy. Medicina (Kaunas) 2020;56:E618. [PMID: 33207848 DOI: 10.3390/medicina56110618] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
16 Doyle AD, Masuda MY, Kita H, Wright BL. Eosinophils in Eosinophilic Esophagitis: The Road to Fibrostenosis is Paved With Good Intentions. Front Immunol 2020;11:603295. [PMID: 33335531 DOI: 10.3389/fimmu.2020.603295] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
17 Yamamoto K, Okamoto T, Fukuda K. Asymptomatic Eosinophilic Infiltration with Endoscopic and Histological Findings Consistent with Eosinophilic Gastritis. Case Rep Gastroenterol 2021;15:652-6. [PMID: 34720822 DOI: 10.1159/000516688] [Reference Citation Analysis]
18 Jin H, Trogen B, Nowak-wegrzyn A. Eosinophilic esophagitis as a complication of food oral immunotherapy. Current Opinion in Allergy & Clinical Immunology 2020;20:616-23. [DOI: 10.1097/aci.0000000000000688] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Woo W, Aceves SS. The role of the allergist in the management of eosinophilic esophagitis. Curr Opin Gastroenterol 2021;37:390-6. [PMID: 34059605 DOI: 10.1097/MOG.0000000000000746] [Reference Citation Analysis]
20 Nowak-Wegrzyn A, Sato S, Fiocchi A, Ebisawa M. Oral and sublingual immunotherapy for food allergy. Curr Opin Allergy Clin Immunol 2019;19:606-13. [PMID: 31524655 DOI: 10.1097/ACI.0000000000000587] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
21 Collins MH, Martin LJ, Wen T, Abonia JP, Putnam PE, Mukkada VA, Rothenberg ME. Eosinophilic Esophagitis Histology Remission Score: Significant Relations to Measures of Disease Activity and Symptoms. J Pediatr Gastroenterol Nutr 2020;70:598-603. [PMID: 31977951 DOI: 10.1097/MPG.0000000000002637] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
22 Schreiner P, Biedermann L, Greuter T, Wright BL, Straumann A. How to approach adult patients with asymptomatic esophageal eosinophilia. Dis Esophagus 2021;34:doaa105. [PMID: 33016307 DOI: 10.1093/dote/doaa105] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
23 Wilson JM, Li RC, McGowan EC. The Role of Food Allergy in Eosinophilic Esophagitis. J Asthma Allergy 2020;13:679-88. [PMID: 33364787 DOI: 10.2147/JAA.S238565] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Leonard SA, Laubach S, Wang J. Integrating oral immunotherapy into clinical practice. J Allergy Clin Immunol 2021;147:1-13. [PMID: 33436161 DOI: 10.1016/j.jaci.2020.11.011] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Manresa MC, Chiang AWT, Kurten RC, Dohil R, Brickner H, Dohil L, Herro R, Akuthota P, Lewis NE, Croft M, Aceves SS. Increased Production of LIGHT by T Cells in Eosinophilic Esophagitis Promotes Differentiation of Esophageal Fibroblasts Toward an Inflammatory Phenotype. Gastroenterology 2020;159:1778-1792.e13. [PMID: 32712105 DOI: 10.1053/j.gastro.2020.07.035] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
26 Rossi CM, Lenti MV, Merli S, Licari A, Votto M, Marseglia GL, Di Sabatino A. Primary eosinophilic gastrointestinal disorders and allergy: Clinical and therapeutic implications. Clin Transl Allergy 2022;12:e12146. [PMID: 35620572 DOI: 10.1002/clt2.12146] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]